ARGX
argenx SE
Company Overview
| Mkt Cap | $51.01B | Price | $818.50 |
| Volume | 402.89K | Change | -0.23% |
| P/E Ratio | 61.2 | Open | $828.85 |
| Revenue | $2.2B | Prev Close | $820.36 |
| Net Income | $833.0M | 52W Range | $510.06 - $855.46 |
| Div Yield | N/A | Target | $851.95 |
| Overall | 91 | Value | -- |
| Quality | -- | Technical | 91 |
No chart data available
Stock Overview
Updated Dailyargenx SE (ARGX) is a leading Healthcare company in the Biotechnology industry, currently trading at $818.50 with a market capitalization of $51.01 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ARGX with a volume of 403K shares. The stock opened up 1.03% from yesterday's close of $820.36. Current analyst estimates project earnings of $16.07 per share for this year, with next year targeting $24.55.
ARGX demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ORTH-CA, OTIC, OTLC, OTLK.
Key investment considerations for ARGX include excellent overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 4.1%. The stock shows neutral valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 04:51 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARGX | $818.50 | -0.2% | 402.89K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |